Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Melioidosis | 1 | 2018 | 50 | 0.73 | Why? |
| Bacteremia | 4 | 2018 | 1372 | 0.37 | Why? |
| Singapore | 10 | 2020 | 3641 | 0.31 | Why? |
| Carbapenems | 2 | 2019 | 343 | 0.30 | Why? |
| Escherichia coli Infections | 1 | 2004 | 348 | 0.20 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2018 | 36 | 0.19 | Why? |
| Burkholderia pseudomallei | 1 | 2018 | 35 | 0.19 | Why? |
| Cryptococcus gattii | 1 | 2017 | 12 | 0.18 | Why? |
| Polymyxin B | 1 | 2019 | 93 | 0.18 | Why? |
| Nod2 Signaling Adaptor Protein | 1 | 2017 | 39 | 0.18 | Why? |
| Daptomycin | 1 | 2018 | 64 | 0.17 | Why? |
| Cryptococcosis | 1 | 2017 | 97 | 0.16 | Why? |
| Lung Diseases, Fungal | 1 | 2017 | 167 | 0.16 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2019 | 214 | 0.16 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.16 | Why? |
| Myelodysplastic Syndromes | 1 | 2019 | 261 | 0.15 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.15 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.15 | Why? |
| Pneumonia, Pneumococcal | 1 | 2018 | 251 | 0.15 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
| RNA Virus Infections | 1 | 2017 | 231 | 0.14 | Why? |
| Printing, Three-Dimensional | 1 | 2021 | 624 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2017 | 273 | 0.14 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.14 | Why? |
| Respiratory Tract Infections | 3 | 2020 | 6817 | 0.14 | Why? |
| Leukemia | 1 | 2019 | 598 | 0.13 | Why? |
| Gram-Negative Bacteria | 1 | 2018 | 473 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.13 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.12 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.12 | Why? |
| Drug Resistance, Bacterial | 2 | 2019 | 1414 | 0.12 | Why? |
| Lymphoma | 1 | 2017 | 522 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Hematologic Diseases | 1 | 2017 | 614 | 0.10 | Why? |
| RNA Viruses | 1 | 2017 | 824 | 0.10 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.09 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.08 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.07 | Why? |
| Hospitals, General | 2 | 2020 | 711 | 0.07 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.05 | Why? |
| Early Diagnosis | 2 | 2020 | 2443 | 0.05 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.05 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2004 | 12361 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Protective Devices | 1 | 2004 | 493 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2017 | 11 | 0.05 | Why? |
| Lung | 2 | 2017 | 31049 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.05 | Why? |
| Reactive Nitrogen Species | 1 | 2017 | 36 | 0.05 | Why? |
| Tablets | 1 | 2019 | 219 | 0.05 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2019 | 264 | 0.04 | Why? |
| Cell Biology | 1 | 2017 | 36 | 0.04 | Why? |
| Ileum | 1 | 2019 | 233 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Tropical Climate | 1 | 2017 | 179 | 0.04 | Why? |
| Male | 11 | 2020 | 367725 | 0.04 | Why? |
| Symptom Assessment | 2 | 2020 | 4967 | 0.04 | Why? |
| Virology | 1 | 2020 | 489 | 0.04 | Why? |
| Base Sequence | 1 | 2004 | 3581 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2018 | 1256 | 0.04 | Why? |
| Triazoles | 1 | 2019 | 440 | 0.03 | Why? |
| Aged | 7 | 2020 | 215776 | 0.03 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| DNA, Viral | 1 | 2004 | 2521 | 0.03 | Why? |
| Female | 9 | 2020 | 380317 | 0.03 | Why? |
| Luminescent Measurements | 1 | 2018 | 924 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Equipment Design | 1 | 2021 | 3095 | 0.03 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.02 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.02 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Radiology | 1 | 2020 | 1199 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Genotype | 1 | 2019 | 4697 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Liver | 1 | 2021 | 4007 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.02 | Why? |
| Contact Tracing | 1 | 2004 | 8448 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 13720 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| SARS Virus | 1 | 2004 | 13021 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
Tan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_